Burning Rock Biotech
BNR
62 hedge funds and large institutions have $243M invested in Burning Rock Biotech in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 38 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0.09% less ownership
Funds ownership: 3.15% → 3.06% (-0.09%)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
28% less funds holding
Funds holding: 86 → 62 (-24)
51% less capital invested
Capital invested by funds: $491M → $243M (-$248M)
63% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$20.4M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$11.6M |
| 3 |
Millennium Management
New York
|
+$4.26M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$3.47M |
| 5 |
Renaissance Technologies
New York
|
+$2.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$10.2M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$9.66M |
| 3 |
BlackRock
New York
|
-$7.44M |
| 4 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$5.8M |
| 5 |
O
OrbiMed
New York
|
-$5.53M |
BNR Hedge Fund Activity: Q4 2021 in Review
62 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2021, worth a combined $243M — down 51% from $491M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of BNR and 14 opened new positions — a net loss of 24 holders — while 22 trimmed existing stakes and 16 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $20.4M. The largest seller was Jennison Associates, exiting entirely with an estimated $10.2M sold.
- 62 institutional investors held Burning Rock Biotech (BNR) as of Q4 2021, down from 86 in Q3 2021.
- Funds reported $243M of Burning Rock Biotech stock for Q4 2021, down 51% quarter-over-quarter.
- 14 funds opened new Burning Rock Biotech positions in Q4 2021 and 38 closed out, a net change of -24 holders.
- The largest Burning Rock Biotech buyer in Q4 2021 was Massachusetts Financial Services, an estimated $20.4M added.
- The largest Burning Rock Biotech seller in Q4 2021 was Jennison Associates, an estimated $10.2M sold.
Based on aggregated 13F filings for Q4 2021.